Combined use of SGLT2 inhibitors and GLP-1 receptor agonists also significantly increased the risk for falls. (HealthDay News) — Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an ...

Despite promising adherence and persistence data, tirzepatide dose escalation was slower in the real-world than clinical trials in patients with obesity without T2D. Tirzepatide dose escalation is ...

Outbreak mainly affected members of communities with low measles vaccination coverage in New Mexico, Oklahoma, and Texas.

Proportion of adult managed care organizations with availability varied from 24 to 100 percent for SGLT2 inhibitors, 0 to 99 percent for GLP-1 receptor agonists. (HealthDay News) — Many Medicaid ...

The HUGO robotic-assisted surgery system showed a high surgical success rate and favorable rates of grade 3 complications.

Measles may reestablish endemicity, with an estimated 851,300 cases over 25 years at current vaccination rates.

Barriers contributing to underreporting of fatigue also include belief that symptom is sign disease is progressing and attempt to be a “good patient.” A cross-sectional study compared barriers to ...